v3.26.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Significant Segment Expenses

Significant segment expenses are set forth in the following table (in thousands):

 

 

Three Months Ended March 31,

 

 

2026

 

 

2025

 

Revenue

 

$

2,947

 

 

$

5,580

 

Less:

 

 

 

 

 

 

Cost of revenue

 

 

1,718

 

 

 

1,419

 

Sales and marketing

 

 

1,304

 

 

 

3,621

 

Clinical trials and medical affairs

 

 

343

 

 

 

1,264

 

Product development

 

 

205

 

 

 

429

 

Digital

 

 

98

 

 

 

402

 

Quality and regulatory

 

 

266

 

 

 

529

 

General and administrative

 

 

2,744

 

 

 

5,198

 

Other segment items (1)

 

 

2,364

 

 

 

(5,781

)

Net loss

 

$

(6,095

)

 

$

(1,501

)

(1) Other segment items included in Net loss primarily include changes in fair value of warrant liabilities, changes in fair value of debt, changes in fair value of the Revenue Interest Financing, changes in fair value of earn-out liabilities, Warrant Inducement expense, and other income (expense).

Schedule of Long-lived Assets by Geography

Long-lived assets, consisting of property and equipment, net and ROU assets by geography were as follows (in thousands):

 

 

March 31,

 

 

December 31,

 

 

2026

 

 

2025

 

United States

 

$

2,058

 

 

$

2,317

 

All other countries

 

 

 

 

 

 

Long-lived assets

 

$

2,058

 

 

$

2,317